55 related articles for article (PubMed ID: 6109524)
1. [Changes in left ventricular filling in obstructive cardiomyopathies during long term beta blockade].
Roudaut R; Page A; Bricaud H; Dallocchio M; Besse P
Arch Mal Coeur Vaiss; 1980; 73(3):268-75. PubMed ID: 6109524
[TBL] [Abstract][Full Text] [Related]
2. [Pulsed Doppler echocardiographic assessment of diastolic left ventricular hemodynamics in hypertrophic cardiomyopathy: relationship between the mode of left ventricular filling and the distribution of left ventricular hypertrophy].
Oki T; Asai M; Takemura H; Fukuda N; Sakai H; Tominaga T; Murao A; Ohshima C; Kusaka Y; Niki T
J Cardiogr; 1983 Sep; 13(3):523-35. PubMed ID: 6687193
[TBL] [Abstract][Full Text] [Related]
3. [Outcome of hypertrophic and obstructive myocardiopathies treated with high doses of propranolol].
Bourmayan C; Dussaule JC; Artigou JY; Fournier C; Fernandez F; Desnos M; Gerbaux A; Gay J
Arch Mal Coeur Vaiss; 1985 Sep; 78(9):1409-16. PubMed ID: 3936444
[TBL] [Abstract][Full Text] [Related]
4. [Relaxation and rapid filling of the left ventricle in essential hypertension during treatment with a non-selective beta blocker].
Sirakova V; Penkov N; Kaponov Kh
Vutr Boles; 1987; 26(3):33-8. PubMed ID: 2887071
[TBL] [Abstract][Full Text] [Related]
5. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
[TBL] [Abstract][Full Text] [Related]
6. [Nifedipine in the treatment of hypertrophic non-obstructive cardiomyopathy].
Senn M; Hess OM; Krayenbühl HP
Schweiz Med Wochenschr; 1982 Sep; 112(38):1312-7. PubMed ID: 6215710
[TBL] [Abstract][Full Text] [Related]
7. [Maximum rate of left ventricular volume change--a parameter of ventricular function (author's transl)].
Spiller P; Benn M; Jehle J; Neuhaus KL; Schmiel FK; Sauer G
Z Kardiol; 1980 Feb; 69(2):110-9. PubMed ID: 7192911
[TBL] [Abstract][Full Text] [Related]
8. [Immediate hemodynamic response to atrioventricular+ stimulation in severe hypertrophic obstructive myocardiopathy].
Tascón Pérez JC; Albarrán A; Trevilla G; Alonso Gutiérrez M; Andreu Dussac J; Lombera Romero F; Escribano Subías P; Hernández Afonso J; Hernández Hernández F; Coma Samartín R; Rodríguez García J; García Cosío F
Rev Esp Cardiol; 1996 Nov; 49(11):815-22. PubMed ID: 9082492
[TBL] [Abstract][Full Text] [Related]
9. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
Haberer T; Hess OM; Jenni R; Krayenbühl HP
Z Kardiol; 1983 Sep; 72(9):487-93. PubMed ID: 6415946
[TBL] [Abstract][Full Text] [Related]
10. [Left ventricular relaxation in myocardial diseases. Hemodynamic study].
Forman J; Lecannelier E; Degroote AC; Faure P; Haquin G; Martin JP; Giraud JP; Maurice P
Arch Mal Coeur Vaiss; 1981 Jun; 74(6):695-703. PubMed ID: 6794491
[TBL] [Abstract][Full Text] [Related]
11. Effect of acute administration of propranolol on ventricular function in hypertrophic obstructive cardiomyopathy measured by non-invasive techniques.
Saenz de la Calzada C; Ziady GM; Hardarson T; Curiel R; Goodwin JF
Br Heart J; 1976 Aug; 38(8):798-803. PubMed ID: 987791
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy.
Ruzyłło W; Chojnowska L; Demkow M; Witkowski A; Kuśmierczyk-Droszcz B; Piotrowski W; Rausinska L; Karcz M; Małecka L; Rydlewska-Sadowska W
Eur Heart J; 2000 May; 21(9):770-7. PubMed ID: 10739733
[TBL] [Abstract][Full Text] [Related]
13. [Diastolic and systolic functions of the left ventricle determined by M-echocardiography in idiopathic hypertrophic cardiomyopathy].
Tomov I; Kaloianova A; Terzieva L; Khalacheva S; Shabani R
Vutr Boles; 1983; 22(5):80-6. PubMed ID: 6687023
[TBL] [Abstract][Full Text] [Related]
14. [Diastolic filling of the right ventricle in hypertrophic cardiomyopathy studied with 2-dimensional Doppler echocardiography].
Okamoto M; Kinoshita N; Miyatake K; Nagata S; Beppu S; Park YD; Pyon ZF; Sakakibara H; Nimura Y
J Cardiogr; 1983 Mar; 13(1):79-88. PubMed ID: 6685744
[TBL] [Abstract][Full Text] [Related]
15. Combination of disopyramide and propranolol in hypertrophic cardiomyopathy.
Cokkinos DV; Salpeas D; Ioannou NE; Christoulas S
Can J Cardiol; 1989; 5(1):33-6. PubMed ID: 2920304
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs.
Alvares RF; Goodwin JF
Br Heart J; 1982 Sep; 48(3):204-12. PubMed ID: 6125160
[TBL] [Abstract][Full Text] [Related]
17. Effect of beta-blockade on symptomatic dexamethasone-induced hypertrophic obstructive cardiomyopathy in premature infants: three case reports and literature review.
Fritz KI; Bhat AM
J Perinatol; 1998; 18(1):38-44. PubMed ID: 9527943
[TBL] [Abstract][Full Text] [Related]
18. Controlled clinical trial of beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy (HOCM).
Hubner P; Ziady G; Lane G; Pridie R; Scales J
Br Heart J; 1972 Sep; 34(9):963. PubMed ID: 4403883
[No Abstract] [Full Text] [Related]
19. [Clinical and instrumental characteristics of idiopathic hypertrophic cardiomyopathy and dynamics of echocardiographic indices as affected by beta-adrenergic blockaders].
Barats SS; Kheĭnonen IM; Klets FKh; Serebrennikov VA; Lipchenko AA
Kardiologiia; 1983 Oct; 23(10):9-12. PubMed ID: 6139501
[TBL] [Abstract][Full Text] [Related]
20. [Case of hypertrophic cardiomyopathy with ventricular blood flow disparity after withdrawal of adrenergic beta antagonists].
Bato K; Fukunaga Y; Fukuzaki M; Kawahata K
Nihon Naika Gakkai Zasshi; 1997 Oct; 86(10):1964-6. PubMed ID: 9445885
[No Abstract] [Full Text] [Related]
[Next] [New Search]
